Lv5
808 积分 2021-11-10 加入
Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy
1天前
已完结
Comparison of HER2-targeted affibody conjugates loaded with auristatin- and maytansine-derived drugs
21天前
已完结
PDPN positive CAFs contribute to HER2 positive breast cancer resistance to trastuzumab by inhibiting antibody-dependent NK cell-mediated cytotoxicity
22天前
已完结
Detailed curriculum vitae of HER2-targeted therapy
23天前
已完结
Spatiotemporal Quantification of HER2-targeting Antibody–Drug Conjugate Bystander Activity and Enhancement of Solid Tumor Penetration
24天前
已完结
Branched pegylated linker-auristatin to control hydrophobicity for the production of homogeneous minibody-drug conjugate against HER2-positive breast cancer
24天前
已完结
Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy
24天前
已完结
HER2 evaluation for clinical decision making in human solid tumours: pearls and pitfalls
24天前
已完结
HER-2 positive gastric cancer: Current targeted treatments
25天前
已完结
HER2-targeted therapies beyond breast cancer — an update
25天前
已完结
皖公网安备34019202002308
